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This insightful state-of-the-art article reviews lower uri-
nary tract symptoms (LUTS) and their interface with “so-
called” benign prostatic hyperplasia (BPH), in particular,
emphasising that LUTS are not just related to the prostate.
Highlighting the importance of looking beyond the symp-
toms, beyond the prostate at not just the potential for a
treatment, but rather at the underlying functional basis
for the symptomatology. It is essential to take into account
not only the patients’ LUTS, but their general medical
history, drug history and comorbidities and to carefully
evaluate patients with a voiding diary, particularly where
nocturia is a significant symptom. It is now well-
established that the term LUTS includes storage, voiding
and post-micturition symptoms. In particular it is the
storage symptoms that lead to the majority of patients
with “BPH” presenting to see us as urologists. It has been
recognised for over 40 years that the bladder is an unre-
liable witness and that LUTS are not disease specific.
Nevertheless, in 2017 there is still a tendency for the term
“BPH” to be used as though it is a clinical condition, as is
also the case for the storage symptoms designated by the
term “overactive bladder symptom complex (OAB)”, when
in fact, the terms descried a collection of relatively non
disease specific symptoms.
LUTS undoubtedly produce significant interference with
quality of life and activities of daily living relating to both
work and social activities. An increased prevalence of LUTS
is associated with sexual dysfunction and the metabolic
syndrome [1]. Indeed, it is the underlying detrusor over-
activity which is seen in two thirds of patients with benign
prostatic obstruction, which has been the subject of
considerable scientific research in the past. The principal
emphasis has been on potential detrusor muscle dysfunc-
tion. There has been comprehensive investigation of
detrusor muscle morphology on microscopy, but it is diffi-
cult to separate out changes relating to aging from those
responsible for altered detrusor muscle function [2].
Brading [3] used an animal model comprising adolescent
female pigs with an obstructing ring placed around the
urethra to evaluate his hypothesis that there is neuromus-
cular dysfunction resulting in denervation hypersensitivity.
A plethora of other animal models using a similar design
followed over the years. A limitation of any such model is
that the innervation of the lower urinary tract in many
animals such as rodents is very different from that seen in a
primate. Furthermore, how representative is an immature
animal (often female) of the situation seen in an aging male
and what is the nature of the underlying neuro-
pathophysiological aetiology? In this context it is important
to recall that detrusor overactivity is in fact uncommon in
male patients presenting with a urethral strictures. With
these reservations in mind, it is not surprising to recall that
none of the animal models have ever resulted directly in
the development of any new pharmaco-therapeutic agents.
Contemporary opinion supports the view that storage
LUTS (OAB) are likely to be the consequences of altered
afferent nerve stimulation consequent upon a combination
of mechanical obstruction to the bladder, ageing and
incidental neurological dysfunction [4]. This afferent hy-
pothesis is supported by an old observations that if
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lidocaine is injected into the prostate in a patient under-
going urodynamics then bladder overactivity is ameliorated
[5]. It can be further hypothesised that in fact prostatic
therapies such as transurethral resection of the prostate
(TURP) and laser therapy that either ablate or resect the
prostatic urothelium result in a deafferentation of the
prostatic urethra which ameliorates the storage symptoms,
which are indeed known to improve following such therapy.
There are significant ultrastructural changes in the
obstructed bladder and it has been suggested that lower uri-
nary tract obstruction in the male is the principal cause of
bladder hypertrophy [6]. Conversely it must be remembered
that in the female patient bladder overactivity and not
obstruction is the principal cause of hypertrophy of the
bladder [7].Whilst somedata published to datedo support the
hypothesis that obstruction is the primary cause of detrusor
hypertrophy it is also very important to consider that detrusor
overactivity is present in the majority of these patients.
Furthermore, voiding only occupies a fraction of the bladder’s
functional time, and I would speculate that in the male, just
as in the female, it is overactivity which is the principal cause
of the bladder wall thickening which is also very evident in
patients with neuropathic bladder dysfunction.
Conversely, it is important to consider the potential for
detrusor underactivity being present. In this context
the concept of “voiding efficiency” is of great importance
(the ratio of post voiding residual to functional capacity
[residual þ average voided volume]); a voiding efficiency
of >40% should be considered as the threshold at which
consideration should be given to a pressure flow urody-
namic assessment to exclude detrusor underactivity.
Patients should be evaluated holistically and urologists
and other clinicians need to adopt a tailored approach to
the management of LUTS. It is only by using this approach
to the management of patients that we can move beyond
the term BPH and the mechanistic concept of reaching for
the prescription pad or surgical instruments to improve
these patients’ quality of life.
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